COMPARATIVE ANALYSIS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
Abstract
The analysis of 180 case histories of patients with atrial fibrillation admitted for inpatient treatment was carried out. The aim of the work was a comparative analysis of antithrombotic therapy.
References
Список литературы
Голухова Е.З., Громова О.И., Булаева Н.И. и др. Эпикардиальный жир и фибрилляция предсердий: роль профиброгенных медиаторов. Кардиология. 2018; 58: 58 - 64.
Ревишвили А.Ш., Шляхто Е.В., Попов С.В. и др. Российские клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. - Москва: ВНОА, 2017. - 701 с.
Бокерия Л.А., Бокерия О.Л., Голухова Е.З. и др. Клинические рекомендации: «Фибрилляция предсердий». ФГБУ ННПЦССХ им. А.Н. Бакулева» МЗ РФ - Москва, 2017. - 65 с.
Панченко Е.П. Антитромботическая терапия в кардиологии. Москва: Ремедиум, 2019. - 255 с.
Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А. и соавт. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 1: методология исследования и оценка эффективности. Рациональная Фармакотерапия в Кардиологии. 2018; 14(5): 664 - 669.
Миронов Н.Ю., Влодзяновский В.В., Юричева Ю.А. и соавт. Проспективное рандомизированное исследование эффективности и безопасности электрической и медикаментозной кардиоверсии при персистирующей фибрилляции предсердий. Часть 2: оценка безопасности. Рациональная фармакотерапия в кардиологии. 2018; 14(6): 826 - 830.
References
Golukhova E.Z., Gromova O.I., Bulaeva N.I. et al. Epicardial fat and atrial fibrillation: the role of profibrogenic mediators. Cardiology. 2018; 58: 58 - 64.
Revishvili A.Sh., Shlyakhto E.V., Popov S.V., etc. Russian clinical guidelines for electrophysiological studies, catheter ablation and the use of implantable antiarrhythmic devices. - Moscow: VNOA, 2017. - 701 p.
Bokeria L.A., Bokeria O.L., Golukhova E.Z., etc. Clinical recommendations: “Atrial fibrillation”. A.N. Bakulev Federal State Budgetary Educational Institution” Ministry of Health of the Russian Federation - Moscow, 2017. - 65 p.
Panchenko E.P. Antithrombotic therapy in cardiology. Moscow: Remedium, 2019. - 255 p.
Mironov N.Yu., Wlodzyanovsky V.V., Yuricheva Yu.A. and coauthors. A prospective randomized study of the efficacy and safety of electrical and drug-induced cardioversion in persistent atrial fibrillation. Part 1: Research methodology and performance evaluation. Rational Pharmacotherapy in Cardiology. 2018; 14(5): 664 - 669.
Mironov N.Yu., Wlodzyanovsky V.V., Yuricheva Yu.A. and coauthors. A prospective randomized study of the efficacy and safety of electrical and drug-induced cardioversion in persistent atrial fibrillation. Part 2: Safety assessment. Rational pharmacotherapy in cardiology. 2018; 14(6): 826 - 830.
Copyright (c) 2023 O. A. Martynova, T. A. Surina, T. A. Kanunova
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
